alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IIB 

110TH CONGRESS 

2D SESSION H. R. 1312 

IN THE SENATE OF THE UNITED STATES 

APRIL 2, 2008 

Received; read twice and referred to the Committee on the Judiciary 

AN ACT 

To expedite adjudication of employer petitions for aliens of 

extraordinary artistic ability. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


smartinez on PRODPC60 with BILLS
2 

HR 1312 RFS 

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Arts Require Timely 

3 Service (ARTS) Act’’. 

4 SEC. 2. EXPEDITED ADJUDICATION OF EMPLOYER PETI5 TIONS FOR ALIENS OF EXTRAORDINARY AR6 TISTIC ABILITY. 

7 Section 214(c) of the Immigration and Nationality 

8 Act (8 U.S.C. 1184(c)) is amended— 

9 (1) by striking ‘‘Attorney General’’ each place 

10 it appears and inserting ‘‘Secretary of Homeland Se11 curity’’; and 

12 (2) in paragraph (6)(D)— 

13 (A) by striking ‘‘(D) Any’’ and inserting 

14 ‘‘(D)(i) Any’’; 

15 (B) by striking ‘‘Once the’’ and inserting 

16 ‘‘Except as provided in clause (ii), once the’’; 

17 and 

18 (C) by adding at the end the following: 

19 ‘‘(ii) The Secretary of Homeland Security shall adju20 dicate each petition for an alien with extraordinary ability 

21 in the arts (as described in section 101(a)(15)(O)(i)), an 

22 alien accompanying such an alien (as described in clauses 

23 (ii) and (iii) of section 101(a)(15)(O)), or an alien de24 scribed in section 101(a)(15)(P) (other than an alien de25 scribed in section 214(c)(4)(A) (relating to athletes)) not 

26 later than 30 days after— 


smartinez on PRODPC60 with BILLS
3 

HR 1312 RFS 

1 ‘‘(I) the date on which the petitioner submits 

2 the petition with a written advisory opinion, letter of 

3 no objection, or request for a waiver; or 

4 ‘‘(II) the date on which the 15-day period de5 scribed in clause (i) has expired, if the petitioner has 

6 had an opportunity, as appropriate, to supply rebut7 tal evidence. 

8 ‘‘(iii) If a petition described in clause (ii) is not adju9 dicated before the end of the 30-day period described in 

10 clause (ii) and the petitioner is an arts organization de11 scribed in paragraph (3), (5), or (6) of section 501(c) of 

12 the Internal Revenue Code of 1986 and exempt from tax 

13 under section 501(a) of such Code for the taxable year 

14 preceding the calendar year in which the petition is sub15 mitted, or an individual or entity petitioning primarily on 

16 behalf of such an organization, the Secretary of Homeland 

17 Security shall provide the petitioner with the premium18 processing services referred to in section 286(u), without 

19 a fee.’’. 

Passed the House of Representatives April 1, 2008. 

Attest: LORRAINE C. MILLER, 

Clerk. 


smartinez on PRODPC60 with BILLS
EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, James S.J. Manuso, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that the Quarterly Report of SuperGen, Inc. on Form 10-Q for the quarterly period ended March 31, 2010 fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial
condition and results of operations of SuperGen, Inc.

By:

/s/ JAMES S.J. MANUSOName:

James S.J. ManusoTitle:

President and Chief Executive Officer
(Principal Executive Officer)


I,
Michael Molkentin, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of
SuperGen, Inc. on Form 10-Q for the quarterly period ended March 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of
SuperGen, Inc.

By:

/s/ MICHAEL MOLKENTINName:

Michael MolkentinTitle:

Chief Financial Officer
(Principal Financial and Accounting Officer)


---



QuickLinks
<PAGE>   1






                                                                      EXHIBIT 11
                      MICRION CORPORATION AND SUBSIDIARIES
             Statement of Computation of Per Share Earnings (Loss)

<TABLE>
<CAPTION>
                                                                      (UNAUDITED)
                                                                  For the three months
                                                                   ended September 30,
                                                                  1997             1998
                                                                 ------           ------
                                                            (in thousands except per share data)

<S>                                                              <C>              <C>    
Net Income (loss)                                                $  636           $ (894)

(a) Computation of Basic Earnings (Loss) per Share:

Weighted average common shares outstanding:
  Common stock                                                    4,049            4,074
                                                                 ------           ------

 Basic Earnings (Loss) per Share                                 $ 0.16           $(0.22)
                                                                 ======           ======

(b) Computation of Diluted Earnings (Loss) per Share:

Weighted average common equivalent shares outstanding:
  Common stock                                                    4,049            4,074
  Common stock equivalents:
    Warrants(1)                                                      68               --
    Options (2)                                                     257               --
                                                                 ------           ------
Weighted average common and
common equivalent shares
outstanding                                                       4,374            4,074
                                                                 ======           ======

Diluted Earnings (Loss) per Share                                $ 0.15           $(0.22)
                                                                 ======           ======
</TABLE>


(1) Warrants issued 5/94 for 100,000 shares, less shares reacquired under the
    treasury stock method.

(2) Options granted 12/94 through 8/98, less shares reacquired under the
    treasury stock method.
EXHIBIT 13

                  SARBANES-OXLEY ACT SECTION 906 CERTIFICATIONS

In connection with this annual report on Form 20-F/A of Tevecap S.A. for the
period ended December 31, 2003, Leila Abraham Loria, Chief Executive Officer of
Tevecap S.A. and Carlos Eduardo Malagoni, Chief Financial Officer of Tevecap
S.A., each hereby certify pursuant to 18 U.S.C.ss.1350, as adopted pursuant
toss.906 of the Sarbanes-Oxley Act of 2002, that:

1. this Form 20-F/A for the period ended December 31, 2003 fully complies with
the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934; and

2. the information contained in this Form 20-F/A for the period ended December
31, 2003 fairly presents, in all material respects, the financial condition and
results of operations of Tevecap S.A.

Date: September 27, 2004     /s/ Leila Abraham Loria
                             -----------------------
                             Leila Abraham Loria
                             Chief Executive Officer


Date: September 27, 2004     /s/ Carlos Eduardo Malagoni
                             ---------------------------
                             Carlos Eduardo Malagoni
                             Chief Financial Officer

A signed original of this written statement required by Section 906 has been
provided to Tevecap S.A. and will be retained by Tevecap S.A. and furnished to
the Securities and Exchange Commission or its staff upon request.


                                       58
<PAGE>   1

                                                                     EXHIBIT 3.3

                            CERTIFICATE OF SECRETARY

                                       OF

                            MEADE INSTRUMENTS CORP.,
                             A DELAWARE CORPORATION

     The undersigned, Steven G. Murdock, does hereby certify that he is the
Secretary of Meade Instruments Corp., a Delaware corporation (the "Company"),
and that attached hereto as Exhibit A is a true, complete and correct copy of
the amendment to Article III, Section 3.02(a), of the Amended and Restated
Bylaws of the Company, adopted effective as of March 1, 2000.

     IN WITNESS WHEREOF, the undersigned has signed his name to this certificate
this 1st day of March, 2000.


                                       /s/ Steven G. Murdock
                                       -----------------------------------------
                                           Steven G. Murdock
                                           Secretary


<PAGE>   2

                                    EXHIBIT A

                  AMENDMENT TO ARTICLE III, SECTION 3.02(a), OF
                       THE AMENDED AND RESTATED BYLAWS OF
                            MEADE INSTRUMENTS CORP.,
                             A DELAWARE CORPORATION

     The second sentence of Article III, Section 3.02(a), of the Amended and
Restated Bylaws is hereby amended to read in its entirety as follows:

          "The exact number of directors shall be six (6) until changed, within
          the limits specified above, by resolution, duly approved by the Board
          of Directors."
Exhibit 99.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of U.S. Restaurant Properties, Inc. (the "Company") on Form 10-K for the year ended
December 31, 2002 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert J. Stetson, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

/s/
Robert J. Stetson

---

Robert J. Stetson
Chief Executive Officer
March 31, 2003

---

QuickLinks
| (1)   | the Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  Dated:        | October 26, 2011 | /s/ James A. Hughes                                        |
|--------------------------------------------------------|------------------|------------------------------------------------------------|
|                                                   |             |  James A. Hughes                                      |
|                                                   |             |  President and Chief Executive Officer                |
|                                                   |             |                                                       |
|  Dated:                                 | October 26, 2011 | /s/ Alan J. Bedner, Jr.                          |
|                                                   |             |  Alan J. Bedner, Jr.                                  |
|                                                   |             |  Executive Vice President and Chief Financial Officer |

----
```

[Congressional Record Volume 141, Number 80 (Monday, May 15, 1995)]
[House]
[Page H4957]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                     EXECUTIVE COMMUNICATIONS, ETC.

  Under clause 2 or rule XXIV, executive communications were taken from 
the Speaker's table and referred as follows:

       876. A letter from the Secretary of Energy, transmitting a 
     draft of proposed legislation to authorize the Department of 
     Energy to sell Eklutna and Snettisham projects administered 
     by the Alaska Power Administration, and for other purposes; 
     jointly, to the Committees on Resources, Commerce, Ways and 
     Means, the Judiciary, Transportation and Infrastructure, 
     Government Reform and Oversight, and the Budget.
     

                          ____________________
```
Exhibit 32.2





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report on Form 10-K of Echo Therapeutics, Inc. (the “Company”) for the fiscal year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Harry G. Mitchell, Chief Operating Officer, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





/s/ Harry G. MitchellHarry G. MitchellChief Operating Officer, Chief Financial Officer andTreasurerMarch 18, 2011
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors of the NIH Clinical Center.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the CLINICAL CENTER, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee*: Board of Scientific Counselors of the NIH Clinical Center.                    

*Date*: October 4-5, 2010.                    

*Time*: 8 a.m. to 2 p.m.                    

*Agenda*: To review and evaluate the Department of Rehabilitation Medicine.                    

*Place*: National Institutes of Health, Building 10, 10 Center Drive, Room 4-2551, Bethesda, MD 20892.                    

*Contact Person*: David K Henderson, MD, Deputy Director for Clinical Care, Office of the Director, Clinical Center, National Institutes of Health, Building 10, Room 6-1480, Bethesda, MD 20892, (301) 496-3515.                    

This notice is being published less than 15 days prior to the meeting due to the urgent need to meet timing limitations imposed by the intramural research review cycle.

Dated: September 17, 2010.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-24145 Filed 9-24-10; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule is an ammended financial data schedule and contains summary
financial information extracted from the balance sheet as of December 31, 1998,
and statements of operations for the twelve months ended December 31, 1998, and
is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                         614,897
<SECURITIES>                                   137,648
<RECEIVABLES>                                  469,392
<ALLOWANCES>                                  (65,000)
<INVENTORY>                                    550,239
<CURRENT-ASSETS>                             1,725,770
<PP&E>                                       2,085,930
<DEPRECIATION>                             (1,047,285)
<TOTAL-ASSETS>                               4,136,590
<CURRENT-LIABILITIES>                        5,053,628
<BONDS>                                         84,968
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        13,920
<OTHER-SE>                                 (1,015,926)
<TOTAL-LIABILITY-AND-EQUITY>                 4,136,590
<SALES>                                      4,309,691
<TOTAL-REVENUES>                             4,309,691
<CGS>                                        3,751,607
<TOTAL-COSTS>                                3,751,607
<OTHER-EXPENSES>                            14,131,872
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,813,208
<INCOME-PRETAX>                           (15,043,371)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (15,043,371)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (15,043,371)
<EPS-BASIC>                                     (1.34)
<EPS-DILUTED>                                   (1.34)


</TABLE>
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 14**  **- 1539** 

THEODORE JUSTICE , Plaintiff

– Appellant ,
v. ROBERT H. HOBGOOD, JR., Senior Resident Superior Court Judge in the Ninth Judicial District, in his individual and official capacity , Defendant

- Appellee
.

Appeal from the United States District Court for the Eastern District of North Carolina , at Raleigh
. W. Earl Britt, Senior District Judge. ( 5:13

- cv - 00677

- BR )

Submitted : November 18, 2014 Decided: November 20, 2014

Before NIEMEYER, MOTZ, and GREGORY , Circuit Judges.

Dismissed by un published per curiam opinion
. Theodore Justice, Appellant Pro Se.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Theodore Justice seeks to appeal the district court’s order reviewing the magistrate judge’s determination and denying Justice’s application to proceed in forma pauperis. Denial of in forma pauperis status is reviewed for abuse of discretion
. See Roberts v. United States Dist. Ct. , 339 U.S. 844, 845 (1950). A review of the record indicates that the district court did not abuse its discretion. Accordingly, we dismiss the appeal on the reasoning of the district court. Justice v. Hobgood , No. 5:13

- cv - 00677

- BR (E.D.N.C. May 27, 2014). We deny leave to proceed in forma pauperis. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decis ional process.

DISMISSED
<PAGE>

                                  EXHIBIT 32.1


                           C ERTIFICATION PURSUANT TO
                             18 U.S.C SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Docucorp International, Inc. (the
"Company") on Form 10-K for the year ended July 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Michael
D. Andereck, President and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of Section 13 (a) or
          15 (d) of the Securities and Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.




/s/ Michael D. Andereck
-----------------------------------------
Michael D. Andereck
President and Chief Executive Officer
October 29, 2003


                                       23
#### ARABIE TRANSPORT, L.L.C. v. REEVES DEVELOPMENT, L.L.C.

No. 2011-CC-0151.

Supreme Court of Louisiana.

March 25, 2011.

In re Arable Transport L.L.C; —Plaintiff; Applying For Supervisory and/or Remedial Writs, Parish of Calcasieu, Lake Charles City Court, No. 10-1164; to the Court of Appeal, Third Circuit, No. CW 10-01272.

Denied.
#### J. A. Young v. S. L. Matier & Co.

(No. 2376.)

Appeal from Payette County.

Phelps & Lane, counsel for appellant.

No counsel appeared for appellees.

Opinion by

Will-son, J.

§ 354. *Homestead; proceeds of sale of, not subject to garnishment when; ease stated.*One Johnson being indebted to appellant, the latter garnished appellees. Appellees answered that they were indebted to Johnson by-note for $175, payable in lumber and building material, and that said note was for a part of the purchase money due Johnson on the sale of his homestead. It was proved on the trial that Johnson was a married man; that he owned a homestead in Payette county, which he sold to one Bigby for $1,200, one-half of said amount cash, and the other half for said Bigby’s two notes of $300 each; that said Johnson then purchased and improved a tract of land, intending the same for his homestead. He then sold one of the Bigby notes to appellees for $125 cash and their said note for $175, to be paid in lumber, with which lumber he intended to erect a homestead house on said land. It is clear from the evidence that Johnson intended to so appropriate the said lumber. Upon these facts the trial judge directed the jury to find for the garnishees, and such was the finding and judgment. *Held:*The debt due Johnson by appellees is exempt property, and not subject to garnishment, and the judgment of the trial court is correct. Said debt was a part of the proceeds of the sale of Johnson’s homestead; and he intended, and had made his arrangements, to invest the same in another homestead. Where a homestead is sold with the present and specific intent to re-invest the proceeds in another, such proceeds are not subject to garnishment while in process of such change *424and re-investment, and the evidence in this case brings it within this rule. [Watkins v. Davis, 61 Tex. 414; *ante, §*32.]

February 4, 1888.

Affirmed.